Advice

Discontinuation of docetaxel (Taxotere)

The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.

Medicine details

Medicine name:
docetaxel (Taxotere)
SMC ID:
209/05
Indication:
Hormone refractory metastatic prostate cancer.
Pharmaceutical company
Sanofi-Aventis
BNF chapter
Malignant disease and immunosuppression
Submission type
Full
Status
Withdrawn
Date advice published
07 November 2005
Additional notes

NICE MTA Advice:  SMC Advice is superseded by National Institute for Health and Clinical Excellence (NICE) Multiple Technology Appraisal (MTA)

The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.